Immediate Impact
48 standout
Citing Papers
EGFR signaling pathway as therapeutic target in human cancers
2022 Standout
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
2020 Standout
Works of Y Otani being referenced
Phase II study of the efficacy of gefitinib in patients with non-small cell lung cancer with the EGFR mutations
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y Otani | 84 | 43 | 32 | 53 | 24 | 207 | |
| Robert E. Madden | 78 | 54 | 10 | 50 | 17 | 291 | |
| M. Matoba | 22 | 47 | 32 | 55 | 28 | 285 | |
| Julian Hague | 32 | 27 | 18 | 24 | 16 | 140 | |
| C. Farrell | 22 | 35 | 33 | 97 | 18 | 279 | |
| C. Huang | 61 | 113 | 10 | 82 | 19 | 276 | |
| Masahiro Hirose | 103 | 32 | 10 | 14 | 39 | 257 | |
| H. Sako | 43 | 64 | 12 | 62 | 39 | 161 | |
| D.E. Wood | 40 | 36 | 32 | 14 | 44 | 297 | |
| P.B. Renton | 34 | 55 | 4 | 62 | 20 | 250 | |
| Fabio Ramponi | 175 | 123 | 140 | 29 | 38 | 297 |
All Works
Loading papers...